Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Readnour Robin Shane Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Readnour Robin Shane (Director) has filed a Form 4 on AN2 Therapeutics, Inc.
Txns: Granted 23,742 options to buy @ $5.91, valued at $140.3k
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2022 4 Readnour Robin Shane (Director) has filed a Form 4 on AN2 Therapeutics, Inc.
Txns: Converted 285,156 shares @ $0
Converted 333,135 shares @ $0
Converted 61,491 shares @ $0
Converted 71,839 shares @ $0
Bought 70,716 shares @ $15, valued at $1.1M
Bought 82,618 shares @ $15, valued at $1.2M
Converted 285,156 convertible preferred @ $0
Converted 333,135 convertible preferred @ $0
Converted 61,491 convertible preferred @ $0
Converted 71,839 convertible preferred @ $0
03/24/2022 3 Readnour Robin Shane (Director) has filed a Form 3 on AN2 Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy